Axsome Therapeutics, Inc. Stock Performance
as on March 21, 2026 at 6:59 am IST
Day's Low
Day's High
$155.42$160.03
0.89%
Downside
2.05%
Upside
52 Week's Low
52 Week's High
$86.99$191.5044.53%
Downside
22.11%
Upside
Axsome Therapeutics, Inc. share price movements today
- Previous Close
- $158.88
- Open
- $159.64
- Volume
- 452.5K
- Day's Low - High
- $155.42 - $160.03
- 52 Week Low - High
- $86.99 - $191.50
Axsome Therapeutics, Inc. Historical Returns
- 1 Month Return
- -14.59 %
- 3 Month Return
- + 2.8 %
- 1 Year Return
- + 23.76 %
- 3 Year Return
- + 149.55 %
- 5 Year Return
- + 142.91 %
Axsome Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Axsome Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.1B
EPS (TTM)
-1.0421
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-13.72
Industry PE ratio
7.891681415929203
PEG Ratio
0EBITDA
-160.2M
Revenue (TTM)
638.5M
Profit Margin
-28.69%
Return On Equity TTM
-252.12%
Axsome Therapeutics, Inc. Stock Valuation
Track how Axsome Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Axsome Therapeutics, Inc. in the last 5 years
Lowest (-37.78x)
December 31, 2025
Today (-13.72x)
March 21, 2026
Industry (7.89x)
March 21, 2026
Highest (-8.02x)
June 30, 2022
Today’s Price to Earnings Ratio: -13.72x
Axsome Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Axsome Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $8.1B | 142.91% | -13.72 | -28.69% | |
| BUY | $41.3B | 116.54% | 133.52 | 8.45% | |
| BUY | $116.3B | 110.08% | 29.94 | 32.94% | |
| NA | $32.5B | NA | 114.93 | 5.37% | |
| BUY | $78.0B | 54.71% | 17.8 | 31.41% |
Stock Returns calculator for Axsome Therapeutics, Inc. Stock including INR - Dollar returns
The Axsome Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Axsome Therapeutics, Inc. investment value today
Current value as on today
₹1,33,130
Returns
₹33,130
(+33.13%)
Returns from Axsome Therapeutics, Inc. Stock
₹23,685 (+23.68%)
Dollar Returns*
₹9,445 (+9.44%)
Analyst Recommendation on Axsome Therapeutics, Inc. Stock
Based on 22 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 22 analysts, 90.91% of analysts recommend a 'BUY' rating for Axsome Therapeutics, Inc.. Average target price of $222.47
Axsome Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Axsome Therapeutics, Inc..
What analysts predicted
29.51%UPSIDE
Target Price
$222.47
Current Price
$156.82
Analyzed by
22 Analysts
Target
$222.47
Axsome Therapeutics, Inc. target price $222.47, a slight upside of 29.51% compared to current price of $156.82. According to 22 analysts rating.
Axsome Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Axsome Therapeutics, Inc. Stock has increased by 68% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:68% versus previous 30 day period
Axsome Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Axsome Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Axsome Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Axsome Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Axsome Therapeutics, Inc. News & Key Events
Today's Timeline - 18 February
Wed, 10:41 AM
-Axsome settles patent litigation over SUNOSI, delaying generic entry until 2040, enhancing long-term growth prospects.
Wed, 11:39 AM
-DCF analysis shows Axsome is undervalued by 74.2%, with an intrinsic value of $710.70 per share.
Insights on Axsome Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 11 quarters, 46.7M → 195.99M (in $), with an average increase of 13.2% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -74.91M → -28.55M (in $), with an average increase of 29.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, AXSM stock has moved up by 33.6%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, AXSM has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, AXSM has outperformed top 5 stocks with highest market-cap in its industry
About Axsome Therapeutics, Inc.
| Organisation | Axsome Therapeutics, Inc. |
| Headquarters | One World Trade Center, New York, NY, United States, 10007 |
| Industry | Health Technology |
| CEO | Dr. Herriot Tabuteau M.D. |
| E-voting on shares | Click here to vote |
Key Management of Axsome Therapeutics, Inc.
Name | Title |
|---|---|
Darren Opland | Director of Corporate Communications |
Dr. Herriot Tabuteau M.D. | Founder, Chairman, CEO & President |
Mr. Nick Pizzie CPA, M.B.A. | Chief Financial Officer |
Mr. Mark L. Jacobson M.A. | Chief Operating Officer |
Mr. Hunter Murdock Esq. | General Counsel & Secretary |
Mr. Ari Maizel | Chief Commercial Officer |
FAQs
What is Axsome Therapeutics, Inc. share price today?
Axsome Therapeutics, Inc. share price today is $156.82 as on at the close of the market. Axsome Therapeutics, Inc. share today touched a day high of $160.03 and a low of $155.42.
What is the 52 week high and 52 week low for Axsome Therapeutics, Inc. share?
Axsome Therapeutics, Inc. share touched a 52 week high of $191.5 on and a 52 week low of $86.99 on . Axsome Therapeutics, Inc. stock price today i.e. is closed at $156.82,which is 18.11% down from its 52 week high and 80.27% up from its 52 week low.
What is Axsome Therapeutics, Inc.'s market capitalisation today?
Axsome Therapeutics, Inc. market capitalisation is $0.01T as on .
How to invest in Axsome Therapeutics, Inc. Stock (AXSM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Axsome Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Axsome Therapeutics, Inc. Shares that will get you 0.0096 shares as per Axsome Therapeutics, Inc. share price of $156.82 per share as on March 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Axsome Therapeutics, Inc. Stock (AXSM) from India?
Indian investors can start investing in Axsome Therapeutics, Inc. (AXSM) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Axsome Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Axsome Therapeutics, Inc. share’s latest price of $156.82 as on March 21, 2026 at 1:29 am IST, you will get 0.0638 shares of Axsome Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Axsome Therapeutics, Inc. has given to Indian investors in the last 5 years?
Axsome Therapeutics, Inc. stock has given 142.91% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?